July 23, 2021 How to protect yourself from wildfire smoke — even thousands of miles away Smoke from the nearly 80 wildfires burning more than 1.4 million acres across the U.S. has spread over thousands of miles during the past couple of weeks, raising health and safety concerns for residents of rural communities and major cities alike.
July 17, 2021 US invests millions to breed more test monkeys in wake of COVID-19: report The U.S. government is reportedly investing millions of dollars to breed more monkeys in the name of biomedical research after a shortage of the animals worsened during the COVID-19 pandemic.
July 15, 2021 Cleveland Clinic won't carry controversial Alzheimer's drug The Cleveland Clinic said it will not carry Biogen’s controversial Alzheimer’s drug after a panel of experts “reviewed all available scientific evidence on this medication.”
July 2, 2021 First migraine drug to both block, tackle headaches ‘shifts paradigm’ of treatment Most of Lilly Rockwell’s earliest memories from childhood are plagued with severe headaches to the point of vomiting. Her migraine disease worsened into adulthood as she worried over the impact on her career as a real estate agent, and quality time with family and friends.
July 1, 2021 Does new Alzheimer's drug work? Answers may miss 2030 target When a controversial Alzheimer’s drug won U.S. approval, surprise over the decision quickly turned to shock at how long it might take to find out if it really works — nine years.
June 25, 2021 FDA authorizes Roche drug for severely ill COVID-19 patients The Food and Drug Administration granted emergency approval to Roche’s Actemra (tocilizumab) to boost outcomes among hospitalized COVID-19 patients receiving oxygen and steroid medications.
June 17, 2021 Novartis experimental prostate cancer drug gets FDA breakthrough designation Novartis announced on Wednesday that the FDA granted Breakthrough Therapy designation to an experimental therapy that targets advanced castration-resistant prostate cancer.
June 16, 2021 Regeneron COVID-19 antibody therapy cuts death risk in hospitalized patients lacking immune response Regeneron’s COVID-19 therapy was found to reduce the risk of death in hospitalized patients who had not mounted their own immune response to the virus by up to 20%, the company said Wednesday
June 15, 2021 Sen. Johnson, suspended by YouTube for HCQ content, says early treatment of COVID could've saved thousands Senator Ron Johnson, R-Wis., sounded off Monday on "The Ingraham Angle" after Google-owned YouTube handed down a suspension of his account because he posted a video that contained information about Hydroxychloroquine, a relatively cheap prescription medication used to fight malaria and lupus.
June 10, 2021 2 FDA committee members resign over Biogen Alzheimer's drug approval Fallout over the FDA’s recent decision to grant Biogen’s Alzheimer’s drug accelerated approval has seen two advisory panel members resign.
